 |
|
Home | Recent Investment Analysts’ Ratings Changes for Paratek Pharmaceuticals (PRTK) |
 |
Recent Investment Analysts’ Ratings Changes for Paratek Pharmaceuticals (PRTK)
|
 |
- May 28, 2015
-
Several brokerages have updated their recommendations and price targets on shares of Paratek Pharmaceuticals (NASDAQ: PRTK) in the last few weeks: 5/26/2015 – Paratek Pharmaceuticals is now covered by analysts at BTIG Research. They set a “buy” rating and a $45.00 price target on the stock. 5/15/2015 – Paratek Pharmaceuticals is now covered by analysts […]This article (Recent Investment Analysts’ Ratings Changes for Paratek Pharmaceuticals (PRTK)) was originally developed by and is property of American Banking News.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
- Read more at:http://www.americanbankingnews.com/2015/05/27/recent-investment-analysts-ratings-changes-for-paratek-pharmaceuticals-prtk/
|
 |
|
 |
|
 |
